alcohol and glp 1 medications New research is testing whether GLP-1 (the same ones used for diabetes weight loss) can help reduce use. Early trials show they can lower heavy drinking days and cravings GLP-1 medications: The next big

Clinical trials show superior average weight loss but it carries a significantly higher price point

Our longevity compounding services support providers across telehealth platforms and private practices who prescribe glutathione injections as part of antioxidant, detoxification, and cellular health programs

Body Mass Index (BMI) Sitagliptin Body mass index had no clinically meaningful effect on the pharmacokinetics of sitagliptin based on a composite analysis of Phase I pharmacokinetic data and on a population pharmacokinetic analysis of Phase I and Phase II data

Abstract The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD), a leading cause of chronic liver disease, has increased worldwide along with the epidemics of obesity and related dysmetabolic conditions characterized by impaired glucose metabolism and insulin signaling, such as type 2 diabetes mellitus (T2D)

Viljoen, A